Testosterone Study
We are seeking approximately 60 male participants to take part in a 3-week study evaluating the effectiveness of Qualia Testosterone, a dietary supplement designed to potentially support testosterone levels and overall male vitality.
This is a randomized, double-blind, placebo-controlled study, meaning participants will be randomly assigned to receive either Qualia Testosterone or a placebo, and neither participants nor researchers will know which study product was received until after the study ends.
Participants will take 2 capsules daily in the morning, with or without food, for 3 weeks. The study will involve regular check-ins, self-report questionnaires, and blood tests conducted at a local facility (such as Quest Diagnostics) to measure testosterone levels.
Upon completion of the study, participants will receive a $300 credit at Qualia Life Sciences.
Participation Requirements:
- Provide voluntary, written, informed consent to participate in the study
- Agree to provide a valid cell phone number and are willing to receive communications through text
- Can read and write English
- Willing to not begin taking any new supplements during the study and continue taking any supplements they are currently using regularly
- Willing to complete questionnaires, records, and diaries associated with the study.
- Male participants aged 28-65
- A score ≥27 on the Aging Males Symptom Scale
- Willing and able to visit a local blood draw facility for required blood sample collections
- Live within 20 miles of a suitable blood draw facility
- Willing to not consume any supplements containing Testosterone starting about 2 weeks prior to the baseline blood test test continuing through the intervention period.
Exclusion Criteria:
- Known food intolerances/allergy to any ingredients in the product
- Having any of the following conditions: Psychiatric conditions, neurologic disorders, endocrine disorders, cancer
- Having had a significant cardiovascular event in the past 6 months
- Taking MAO inhibitors, SSRIs, or any other psychiatric or neurological medicines
- On immunosuppressive therapy
- Individuals who were deemed incompatible with the test protocol
- Adults lacking capacity to consent
- Have Hypogonadism
- On Testosterone Replacement Therapy
- Taking Gonadotropin-releasing hormone (GnRH) injections or gonadotropins (hCG or FSH)
This study is being conducted by Qualia Life Science